Company Metabolix, Inc. Nasdaq
Equities
US5910188094
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Oils and Niche Crops
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Lynne Brum
IRC | Investor Relations Contact | 60 | 11-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Anthony Sinskey
FOU | Founder | 83 | 92-05-31 |
Sherri Brown
BRD | Director/Board Member | 63 | 20-02-10 |
Willie Loh
BRD | Director/Board Member | 69 | 22-10-03 |
Company contact information
Yield10 Bioscience, Inc.
19 Presidential Way
01801-1184, Woburn
+(617) 583-1700
http://www.yield10bio.com![address Metabolix, Inc.](https://cdn.zonebourse.com/static/address/36333.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-12.29% | 10.65B |